{"count": 10, "results": [{"_id": "9061270", "pmid": 9061270, "title": "Lisinopril. A review of its pharmacology and clinical efficacy in elderly patients.", "journal": "Drugs Aging", "authors": ["Langtry HD", "Markham A"], "date": "1997-02-01T00:00:00Z", "doi": "10.2165/00002512-199710020-00006", "meta_date_publication": "1997 Feb", "meta_volume": "10", "meta_issue": "2", "meta_pages": "131-66", "score": 50062.53, "text_hl": "Data from the GISSI-3 post-@DISEASE_Myocardial_Infarction @DISEASE_MESH:D009203 @@@myocardial infarction@@@ trial show that @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ reduced mortality and @DISEASE_Ventricular_Dysfunction_Left @DISEASE_MESH:D018487 @@@left ventricular dysfunction@@@ when given for 42 days starting within 24 hours of the onset of @<m>DISEASE_Infarction</m> @DISEASE_MESH:D007238 @@@infarction@@@ symptoms. ", "citations": {"NLM": "Langtry HD, Markham A. Lisinopril. A review of its pharmacology and clinical efficacy in elderly patients. Drugs Aging. 1997 Feb;10(2):131-66. PMID: 9061270", "BibTeX": "@article{9061270, title={Lisinopril. A review of its pharmacology and clinical efficacy in elderly patients.}, author={Langtry HD and Markham A}, journal={Drugs Aging}, volume={10}, number={2}, pages={131-66}}"}}, {"_id": "14614522", "pmid": 14614522, "title": "Potential beneficial as well as detrimental effects of chronic treatment with lisinopril and (or) spironolactone on isolated hearts following low-flow ischemia in normal and infarcted rats.", "journal": "Can J Physiol Pharmacol", "authors": ["Rochetaing A", "Chapon C", "Marescaux L", "Le Bouil A", "Furber A", "Kreher P"], "date": "2003-09-01T00:00:00Z", "doi": "10.1139/y03-081", "meta_date_publication": "2003 Sep", "meta_volume": "81", "meta_issue": "9", "meta_pages": "864-72", "score": 50059.992, "text_hl": "Potential beneficial as well as detrimental effects of chronic treatment with @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ and (or) @CHEMICAL_Spironolactone @CHEMICAL_MESH:D013148 @@@spironolactone@@@ on isolated hearts following low-flow @DISEASE_Ischemia @DISEASE_MESH:D007511 @@@ischemia@@@ in normal and @<m>DISEASE_Infarction</m> @DISEASE_MESH:D007238 @@@infarcted@@@ @SPECIES_10116 @@@rats@@@.", "citations": {"NLM": "Rochetaing A, Chapon C, Marescaux L, Le Bouil A, Furber A, Kreher P. Potential beneficial as well as detrimental effects of chronic treatment with lisinopril and (or) spironolactone on isolated hearts following low-flow ischemia in normal and infarcted rats. Can J Physiol Pharmacol. 2003 Sep;81(9):864-72. PMID: 14614522", "BibTeX": "@article{14614522, title={Potential beneficial as well as detrimental effects of chronic treatment with lisinopril and (or) spironolactone on isolated hearts following low-flow ischemia in normal and infarcted rats.}, author={Rochetaing A and Chapon C and Marescaux L and Le Bouil A and Furber A and Kreher P}, journal={Can J Physiol Pharmacol}, volume={81}, number={9}, pages={864-72}}"}}, {"_id": "14527819", "pmid": 14527819, "title": "Infarct size limiting effect of apstatin alone and in combination with enalapril, lisinopril and ramipril in rats with experimental myocardial infarction.", "journal": "Pharmacol Res", "authors": ["Veeravalli KK", "Akula A", "Routhu KV", "Kota MK"], "date": "2003-12-01T00:00:00Z", "doi": "10.1016/s1043-6618(03)00222-6", "meta_date_publication": "2003 Dec", "meta_volume": "48", "meta_issue": "6", "meta_pages": "557-63", "score": 50057.53, "text_hl": "@<m>DISEASE_Infarction</m> @DISEASE_MESH:D007238 @@@Infarct size@@@ limiting effect of @CHEMICAL_apstatin @CHEMICAL_MESH:C097277 @@@apstatin@@@ alone and in combination with @CHEMICAL_Enalapril @CHEMICAL_MESH:D004656 @@@enalapril@@@, @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ and @CHEMICAL_Ramipril @CHEMICAL_MESH:D017257 @@@ramipril@@@ in @SPECIES_10116 @@@rats@@@ with experimental @DISEASE_Myocardial_Infarction @DISEASE_MESH:D009203 @@@myocardial infarction@@@.", "citations": {"NLM": "Veeravalli KK, Akula A, Routhu KV, Kota MK. Infarct size limiting effect of apstatin alone and in combination with enalapril, lisinopril and ramipril in rats with experimental myocardial infarction. Pharmacol Res. 2003 Dec;48(6):557-63. PMID: 14527819", "BibTeX": "@article{14527819, title={Infarct size limiting effect of apstatin alone and in combination with enalapril, lisinopril and ramipril in rats with experimental myocardial infarction.}, author={Veeravalli KK and Akula A and Routhu KV and Kota MK}, journal={Pharmacol Res}, volume={48}, number={6}, pages={557-63}}"}}, {"_id": "18806625", "pmid": 18806625, "title": "Protective effect of candesartan in experimental ischemic stroke in the rat mediated by AT2 and AT4 receptors.", "journal": "J Hypertens", "authors": ["Faure S", "Bureau A", "Oudart N", "Javellaud J", "Fournier A", "Achard JM"], "date": "2008-10-01T00:00:00Z", "doi": "10.1097/HJH.0b013e32830dd5ee", "meta_date_publication": "2008 Oct", "meta_volume": "26", "meta_issue": "10", "meta_pages": "2008-15", "score": 50057.383, "text_hl": "RESULTS: Inhibition of production of endogenous angiotensins by pretreatment for 24 h with @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ significantly increased mortality and @<m>DISEASE_Infarction</m> @DISEASE_MESH:D007238 @@@infarct@@@ volume, whereas @CHEMICAL_candesartan @CHEMICAL_MESH:C081643 @@@candesartan@@@ for 24 h reduced blood pressure to the same extent but had no deleterious effect. ", "citations": {"NLM": "Faure S, Bureau A, Oudart N, Javellaud J, Fournier A, Achard JM. Protective effect of candesartan in experimental ischemic stroke in the rat mediated by AT2 and AT4 receptors. J Hypertens. 2008 Oct;26(10):2008-15. PMID: 18806625", "BibTeX": "@article{18806625, title={Protective effect of candesartan in experimental ischemic stroke in the rat mediated by AT2 and AT4 receptors.}, author={Faure S and Bureau A and Oudart N and Javellaud J and Fournier A and Achard JM}, journal={J Hypertens}, volume={26}, number={10}, pages={2008-15}}"}}, {"_id": "14730097", "pmid": 14730097, "title": "Nitric oxide- and prostaglandin-mediated cardioprotection by bradykinin in myocardial ischemia and reperfusion injury.", "journal": "Pol J Pharmacol", "authors": ["Veeravalli KK", "Akula A", "Kota MK"], "date": "2003-11-01T00:00:00Z", "meta_date_publication": "2003 Nov-Dec", "meta_volume": "55", "meta_issue": "6", "meta_pages": "1021-9", "score": 50051.04, "text_hl": "A lead II ECG was monitored at various intervals throughout the experiment. @<m>DISEASE_Infarction</m> @DISEASE_MESH:D007238 @@@Infarct size@@@ expressed as percent of left ventricle was found to be 50.5 +/- 3.5 in control animals and was reduced to 19.4 +/- 1.1 and 15.0 +/- 2.1 with the combined treatment of @CHEMICAL_Enalapril @CHEMICAL_MESH:D004656 @@@enalapril@@@ or @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ and @CHEMICAL_Mercaptoethanol @CHEMICAL_MESH:D008623 @@@2-mercaptoethanol@@@, respectively. ", "citations": {"NLM": "Veeravalli KK, Akula A, Kota MK. Nitric oxide- and prostaglandin-mediated cardioprotection by bradykinin in myocardial ischemia and reperfusion injury. Pol J Pharmacol. 2003 Nov-Dec;55(6):1021-9. PMID: 14730097", "BibTeX": "@article{14730097, title={Nitric oxide- and prostaglandin-mediated cardioprotection by bradykinin in myocardial ischemia and reperfusion injury.}, author={Veeravalli KK and Akula A and Kota MK}, journal={Pol J Pharmacol}, volume={55}, number={6}, pages={1021-9}}"}}, {"_id": "10356928", "pmid": 10356928, "title": "[Converting enzyme inhibitors in acute myocardial infarct and heart failure].", "journal": "Med Arh", "authors": ["Arslanagić A", "Raljević E"], "date": "1999-01-01T00:00:00Z", "meta_date_publication": "1999", "meta_volume": "53", "meta_issue": "1", "meta_pages": "29-31", "score": 50050.66, "text_hl": "We introduced the therapy with @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ (@<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lopril@@@), in 70% of @SPECIES_9606 @@@patients@@@ among 2855 @SPECIES_9606 @@@patients@@@ that were admitted in Coronary Care Unit in 1997 and 1998. ", "citations": {"NLM": "Arslanagić A, Raljević E. [Converting enzyme inhibitors in acute myocardial infarct and heart failure]. Med Arh. 1999;53(1):29-31. PMID: 10356928", "BibTeX": "@article{10356928, title={[Converting enzyme inhibitors in acute myocardial infarct and heart failure].}, author={Arslanagić A and Raljević E}, journal={Med Arh}, volume={53}, number={1}, pages={29-31}}"}}, {"_id": "7503242", "pmid": 7503242, "title": "Development and prevention of skeletal muscle structural alterations after experimental myocardial infarction.", "journal": "Am J Physiol", "authors": ["Schieffer B", "Wollert KC", "Berchtold M", "Saal K", "Schieffer E", "Hornig B", "Riede UN", "Drexler H"], "date": "1995-11-01T00:00:00Z", "doi": "10.1152/ajpheart.1995.269.5.H1507", "meta_date_publication": "1995 Nov", "meta_volume": "269", "meta_issue": "5 Pt 2", "meta_pages": "H1507-13", "score": 50050.58, "text_hl": "The present study was designed to assess whether structural alterations develop within skeletal muscle 1 yr after @DISEASE_Myocardial_Infarction @DISEASE_MESH:D009203 @@@myocardial infarction@@@ (MI) and failure and, if so, whether these structural alterations can be prevented by @GENE_ACE @GENE_24310 @@@angiotensin-converting enzyme@@@ (@GENE_ACE @GENE_24310 @@@ACE@@@) inhibition. @<m>DISEASE_Infarction</m> @DISEASE_MESH:D007238 @@@Infarcted@@@ @SPECIES_10116 @@@rats@@@ were randomized and treated for 1 yr with either placebo (MI-IP, n = 9), a low dose of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ (MI-LL, 0.5 mg.kg-1.day-1, n = 12), or a high dose of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ (MI-LH, 5 mg.kg-1.day-1, n = 9). ", "citations": {"NLM": "Schieffer B, Wollert KC, Berchtold M, Saal K, Schieffer E, Hornig B, Riede UN, Drexler H. Development and prevention of skeletal muscle structural alterations after experimental myocardial infarction. Am J Physiol. 1995 Nov;269(5 Pt 2):H1507-13. PMID: 7503242", "BibTeX": "@article{7503242, title={Development and prevention of skeletal muscle structural alterations after experimental myocardial infarction.}, author={Schieffer B and Wollert KC and Berchtold M and Saal K and Schieffer E and Hornig B and Riede UN and Drexler H}, journal={Am J Physiol}, volume={269}, number={5 Pt 2}, pages={H1507-13}}"}}, {"_id": "7955203", "pmid": 7955203, "title": "Survival after myocardial infarction in the rat. Role of tissue angiotensin-converting enzyme inhibition.", "journal": "Circulation", "authors": ["Wollert KC", "Studer R", "von Bülow B", "Drexler H"], "date": "1994-11-01T00:00:00Z", "doi": "10.1161/01.cir.90.5.2457", "meta_date_publication": "1994 Nov", "meta_volume": "90", "meta_issue": "5", "meta_pages": "2457-67", "score": 50048.21, "text_hl": "METHODS AND RESULTS: @<m>DISEASE_Infarction</m> @DISEASE_MESH:D007238 @@@Infarcted@@@ @SPECIES_10116 @@@rats@@@ were randomized to placebo, low-dose @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@, or high-dose @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ (each, n = 80) and compared with sham-operated animals (n = 40). ", "citations": {"NLM": "Wollert KC, Studer R, von Bülow B, Drexler H. Survival after myocardial infarction in the rat. Role of tissue angiotensin-converting enzyme inhibition. Circulation. 1994 Nov;90(5):2457-67. PMID: 7955203", "BibTeX": "@article{7955203, title={Survival after myocardial infarction in the rat. Role of tissue angiotensin-converting enzyme inhibition.}, author={Wollert KC and Studer R and von Bülow B and Drexler H}, journal={Circulation}, volume={90}, number={5}, pages={2457-67}}"}}, {"_id": "14597148", "pmid": 14597148, "title": "Involvement of nitric oxide and prostaglandin pathways in the cardioprotective actions of bradykinin in rats with experimental myocardial infarction.", "journal": "Pharmacol Res", "authors": ["Veeravalli KK", "Akula A"], "date": "2004-01-01T00:00:00Z", "doi": "10.1016/j.phrs.2003.07.010", "meta_date_publication": "2004 Jan", "meta_volume": "49", "meta_issue": "1", "meta_pages": "23-9", "score": 50037.73, "text_hl": "A lead II electrocardiogram was monitored at various intervals throughout the experiment. @<m>DISEASE_Infarction</m> @DISEASE_MESH:D007238 @@@Infarct@@@ size reduction obtained with the combined inhibition of @CHEMICAL_Enalapril @CHEMICAL_MESH:D004656 @@@enalapril@@@ and @CHEMICAL_apstatin @CHEMICAL_MESH:C097277 @@@apstatin@@@, @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ and @CHEMICAL_apstatin @CHEMICAL_MESH:C097277 @@@apstatin@@@ was blocked partially but significantly with the prior administration of @CHEMICAL_NG_Nitroarginine_Methyl_Ester @CHEMICAL_MESH:D019331 @@@L-NAME@@@ (@CHEMICAL_NG_Nitroarginine_Methyl_Ester @CHEMICAL_MESH:D019331 @@@Nomega-nitro-L-arginine methyl ester@@@) or @CHEMICAL_Aspirin @CHEMICAL_MESH:D001241 @@@aspirin@@@, suggesting the involvement of both @CHEMICAL_Nitric_Oxide @CHEMICAL_MESH:D009569 @@@nitric oxide@@@ and @CHEMICAL_Prostaglandins @CHEMICAL_MESH:D011453 @@@prostaglandin@@@ pathways in the cardioprotective actions mediated by bradykinin.", "citations": {"NLM": "Veeravalli KK, Akula A. Involvement of nitric oxide and prostaglandin pathways in the cardioprotective actions of bradykinin in rats with experimental myocardial infarction. Pharmacol Res. 2004 Jan;49(1):23-9. PMID: 14597148", "BibTeX": "@article{14597148, title={Involvement of nitric oxide and prostaglandin pathways in the cardioprotective actions of bradykinin in rats with experimental myocardial infarction.}, author={Veeravalli KK and Akula A}, journal={Pharmacol Res}, volume={49}, number={1}, pages={23-9}}"}}, {"_id": "9107180", "pmid": 9107180, "title": "Differential effects of kinins on cardiomyocyte hypertrophy and interstitial collagen matrix in the surviving myocardium after myocardial infarction in the rat.", "journal": "Circulation", "authors": ["Wollert KC", "Studer R", "Doerfer K", "Schieffer E", "Holubarsch C", "Just H", "Drexler H"], "date": "1997-04-01T00:00:00Z", "doi": "10.1161/01.cir.95.7.1910", "meta_date_publication": "1997 Apr 1", "meta_volume": "95", "meta_issue": "7", "meta_pages": "1910-7", "score": 50032.926, "text_hl": "Additional groups of @<m>DISEASE_Infarction</m> @DISEASE_MESH:D007238 @@@infarcted@@@ @SPECIES_10116 @@@rats@@@ were treated with the ACE inhibitor @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ or the AT1 receptor antagonist @CHEMICAL_ZD_7155 @CHEMICAL_MESH:C095905 @@@ZD7155@@@, each separately and in combination with icatibant. ", "citations": {"NLM": "Wollert KC, Studer R, Doerfer K, Schieffer E, Holubarsch C, Just H, Drexler H. Differential effects of kinins on cardiomyocyte hypertrophy and interstitial collagen matrix in the surviving myocardium after myocardial infarction in the rat. Circulation. 1997 Apr 1;95(7):1910-7. PMID: 9107180", "BibTeX": "@article{9107180, title={Differential effects of kinins on cardiomyocyte hypertrophy and interstitial collagen matrix in the surviving myocardium after myocardial infarction in the rat.}, author={Wollert KC and Studer R and Doerfer K and Schieffer E and Holubarsch C and Just H and Drexler H}, journal={Circulation}, volume={95}, number={7}, pages={1910-7}}"}}]}